ContraFect intends to conduct a public offering of common-share units

Common stock, five-year warrant sold through bookrunner Piper Jaffray

By Devika Patel

Knoxville, Tenn., July 21 – ContraFect Corp. will price a public sale of units, according to a preliminary prospectus supplement filed Thursday with the Securities and Exchange Commission.

The units will consist of common stock and five-year warrants.

Piper Jaffray is the bookrunner.

Proceeds will be used for clinical development, portfolio advancement, product discovery, working capital and general corporate purposes.

The company also terminated its $30 million at-the-market sales agreement with Cowen and Co., LLC on July 21. The agreement was arranged on Jan. 20, and the company had not sold any shares through this deal.

The biotechnology company is based in Yonkers, N.Y.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.